Healthcare Analysts discuss emerging therapies in chronic myeloid leukemia (CML), (relevant companies NVS, ENLV, TERN, TAK, BMY, PFE) on an Analyst/Industry conference call to be held on October 31.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Trump Trade: Trump administration prepares new probe into pharma prices
- Novartis announces expiration of HSR Act waiting period of Tourmaline Bio offer
- Novartis announces Cosentyx met primary endpoint in Phase III REPLENISH trial
- Trump admin prepares new probe into U.S. pharma prices, FT says
- Novartis presents new Pluvicto data, showed improvement in rPFS